Interesting ImagesIntense 68Ga-Pentixafor Activity in Aldosterone-Producing Adrenal AdenomasDing, Jie MD*; Tong, Anli MD†; Zhang, Yushi MD‡; Wen, Jin MD‡; Huo, Li MD, PhD*Author Information From the *Department of Nuclear Medicine and Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine †Department of Endocrinology and Key Laboratory of Endocrinology, Ministry of Health ‡Department of Urological Surgery, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Science and PUMC, Beijing, China. Received for publication November 24, 2019; revision accepted December 2, 2019. Conflicts of interest and sources of funding: This work was sponsored in part by the National Natural Science Foundation of China (grant 81571713), CAMS Innovation Fund for Medical Sciences (CIFMS) (grant 2016-I2M-4-003), CAMS initiative for innovative medicine (grant CAMS-2018-I2M-3-001). None declared to all authors. Correspondence to: Li Huo, MD, PhD, Department of Nuclear Medicine, Peking Union Medical College Hospital, 1# Shuaifuyuan, Dongcheng District, Beijing, China 100730. E-mail: Huoli@pumch.cn. Online date: February 28, 2020 Clinical Nuclear Medicine: April 2020 - Volume 45 - Issue 4 - p 336-339 doi: 10.1097/RLU.0000000000002946 Buy Metrics Abstract 68Ga-pentixafor, a ligand of CXCR4 (CXC chemokine receptor type 4), has been reported as a potential PET tracer to evaluate a variety of pathological entities. We report intense 68Ga-pentixafor activity on PET/CT in 2 patients in the histopathologically confirmed adrenal adenomas, which were the cause of their Conn syndrome. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.